137 related articles for article (PubMed ID: 9292396)
1. Coronary artery disease and antioxidants--is there a role for carvedilol?
Landray MJ; Kendall MJ
J Clin Pharm Ther; 1997 Feb; 22(1):3-5. PubMed ID: 9292396
[No Abstract] [Full Text] [Related]
2. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
Van den Branden C; Gabriels M; Vamecq J; Vanden Houte K; Verbeelen D
Nephron; 1997; 77(3):319-24. PubMed ID: 9375827
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.
Tasset I; Espínola C; Medina FJ; Feijóo M; Ruiz C; Moreno E; Gómez MM; Collado JA; Muñoz C; Muntané J; Montilla P; Túnez I
J Physiol Biochem; 2009 Sep; 65(3):291-6. PubMed ID: 20119823
[TBL] [Abstract][Full Text] [Related]
5. [Multiple action neuro-hormonal antagonist: carvedilol].
Taurand S
Soins; 1997 Oct; (619):61-2. PubMed ID: 9416217
[No Abstract] [Full Text] [Related]
6. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts.
Kramer JH; Weglicki WB
Free Radic Biol Med; 1996; 21(6):813-25. PubMed ID: 8902527
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol for heart failure: more than just a beta-blocker?
Cleland JG
Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection.
Feuerstein GZ; Ruffolo RR
Eur Heart J; 1995 Jul; 16 Suppl F():38-42. PubMed ID: 8521883
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation.
Noguchi N; Nishino K; Niki E
Biochem Pharmacol; 2000 May; 59(9):1069-76. PubMed ID: 10704936
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection.
Yue TL; Lysko PG; Barone FC; Gu JL; Ruffolo RR; Feuerstein GZ
Ann N Y Acad Sci; 1994 Nov; 738():230-42. PubMed ID: 7832432
[TBL] [Abstract][Full Text] [Related]
11. A potent antioxidant, SB209995, inhibits oxygen-radical-mediated lipid peroxidation and cytotoxicity.
Feuerstein R; Yue TL
Pharmacology; 1994 Jun; 48(6):385-91. PubMed ID: 8047557
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol.
Feuerstein G; Yue TL; Ma X; Ruffolo RR
Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):17-24. PubMed ID: 9715819
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension.
Maggi E; Marchesi E; Covini D; Negro C; Perani G; Bellomo G
J Cardiovasc Pharmacol; 1996 Apr; 27(4):532-8. PubMed ID: 8847870
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease.
Matsuda Y; Akita H; Terashima M; Shiga N; Kanazawa K; Yokoyama M
Am Heart J; 2000 Nov; 140(5):753-9. PubMed ID: 11054621
[TBL] [Abstract][Full Text] [Related]
15. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure].
Buchwald A; Unterberg C; van der Does R; Wiegand V
Z Kardiol; 1990 Jun; 79(6):424-8. PubMed ID: 1974100
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol in ischaemic heart disease.
Prichard BN
Cardiology; 1993; 82 Suppl 3():34-9. PubMed ID: 8106163
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism.
Tadolini B; Franconi F
Free Radic Res; 1998 Nov; 29(5):377-87. PubMed ID: 9925030
[TBL] [Abstract][Full Text] [Related]
18. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity.
Oettl K; Greilberger J; Zangger K; Haslinger E; Reibnegger G; Jürgens G
Biochem Pharmacol; 2001 Jul; 62(2):241-8. PubMed ID: 11389884
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?
Wollert KC; Drexler H
Circulation; 2002 Oct; 106(17):2164-6. PubMed ID: 12390940
[No Abstract] [Full Text] [Related]
20. Carvedilol for heart failure, with care.
Cleland JG; Swedberg K
Lancet; 1996 May; 347(9010):1199-201. PubMed ID: 8622445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
